Literature DB >> 18310091

Widespread hyperplasia induced by transgenic TGFalpha in ApcMin mice is associated with only regional effects on tumorigenesis.

Andrea Bilger1, Ruth Sullivan, Amy J Prunuske, Linda Clipson, Norman R Drinkwater, William F Dove.   

Abstract

Using a mouse predisposed to neoplasia by a germ line mutation in Apc (Apc(Min)), we tested whether induced hyperplasia is sufficient to increase intestinal tumor multiplicity or size in the intestine. We found that hyperplasia in the jejunum correlated with a significant increase in tumor multiplicity. However, tumor multiplicity was unchanged in the hyperplastic colon. This result indicates that even an intestine predisposed to neoplasia can, in certain regions including the colon, accommodate net increased cell growth without developing more neoplasms. Where hyperplasia correlated with increased tumor multiplicity, it did not increase the size or net growth of established tumors. This result suggests that the event linking hyperplasia and neoplasia in the jejunum is tumor establishment. Two novel observations arose in our study: the multiple intestinal neoplasia (Min) mutation partially suppressed both mitosis and transforming growth factor alpha-induced hyperplasia throughout the intestine; and zinc treatment alone increased tumor multiplicity in the duodenum of Min mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310091      PMCID: PMC2547353          DOI: 10.1093/carcin/bgn038

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  66 in total

Review 1.  Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death.

Authors:  A Q Truong-Tran; L H Ho; F Chai; P D Zalewski
Journal:  J Nutr       Date:  2000-05       Impact factor: 4.798

2.  Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: perinatal susceptibility, regional variation, and correlation with DNA adducts.

Authors:  I L Steffensen; H A Schut; J E Paulsen; A Andreassen; J Alexander
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

3.  Mlh1 deficiency enhances several phenotypes of Apc(Min)/+ mice.

Authors:  A R Shoemaker; K M Haigis; S M Baker; S Dudley; R M Liskay; W F Dove
Journal:  Oncogene       Date:  2000-05-25       Impact factor: 9.867

4.  Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.

Authors:  Muhammad T Salam; Giske Ursin; Eila C Skinner; Tesfaye Dessissa; Juergen K V Reichardt
Journal:  Urol Oncol       Date:  2005 Jul-Aug       Impact factor: 3.498

5.  Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.

Authors:  P C Chulada; M B Thompson; J F Mahler; C M Doyle; B W Gaul; C Lee; H F Tiano; S G Morham; O Smithies; R Langenbach
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

6.  Dnmt1N/+ reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/6-multiple intestinal neoplasia (Min)/+ mice independently of p53 but demonstrates strong synergy with the modifier of Min 1(AKR) resistance allele.

Authors:  R T Cormier; W F Dove
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

7.  Polyclonality of familial murine adenomas: analyses of mouse chimeras with low tumor multiplicity suggest short-range interactions.

Authors:  Andrew T Thliveris; Richard B Halberg; Linda Clipson; William F Dove; Ruth Sullivan; Mary Kay Washington; Stephen Stanhope; Michael A Newton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

Review 8.  The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.

Authors:  W F Dove; R T Cormier; K A Gould; R B Halberg; A J Merritt; M A Newton; A R Shoemaker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

9.  Atm is a negative regulator of intestinal neoplasia.

Authors:  L N Kwong; K R Weiss; K M Haigis; W F Dove
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

10.  Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers.

Authors:  R B Halberg; D S Katzung; P D Hoff; A R Moser; C E Cole; R A Lubet; L A Donehower; R F Jacoby; W F Dove
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  5 in total

Review 1.  The intestinal stem cell.

Authors:  Luis A Chia; Calvin J Kuo
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

2.  Tsc2, a positional candidate gene underlying a quantitative trait locus for hepatic steatosis.

Authors:  Chen-Yu Wang; Donald S Stapleton; Kathryn L Schueler; Mary E Rabaglia; Angie T Oler; Mark P Keller; Christina M Kendziorski; Karl W Broman; Brian S Yandell; Eric E Schadt; Alan D Attie
Journal:  J Lipid Res       Date:  2012-05-23       Impact factor: 5.922

3.  The Drosophila midgut: a model for stem cell driven tissue regeneration.

Authors:  Elena M Lucchetta; Benjamin Ohlstein
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012-04-09       Impact factor: 5.814

4.  EGFR/Ras/MAPK signaling mediates adult midgut epithelial homeostasis and regeneration in Drosophila.

Authors:  Huaqi Jiang; Marc O Grenley; Maria-Jose Bravo; Rachel Z Blumhagen; Bruce A Edgar
Journal:  Cell Stem Cell       Date:  2010-12-16       Impact factor: 24.633

5.  Tetraspanin 6 is a regulator of carcinogenesis in colorectal cancer.

Authors:  Regina Andrijes; Rahul K Hejmadi; Matthew Pugh; Sundaresan Rajesh; Vera Novitskaya; Maha Ibrahim; Michael Overduin; Chris Tselepis; Gary W Middleton; Balázs Győrffy; Andrew D Beggs; Fedor Berditchevski
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-28       Impact factor: 12.779

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.